ProvONE Study
ClinicalTrials.gov NCT06134232
Research payments
$1,987,458
Through program year 2025, $1,987,458 in research payments was reported against ProvONE Study, across 340 payments, paid by Dendreon Pharmaceuticals LLC.
- Paid by
- Dendreon Pharmaceuticals LLC
- ClinicalTrials.gov
- NCT06134232
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,302,520 | 252 |
| 2024 | Research | $684,938 | 88 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Paul Sieber Lancaster, PA Named on 27 payments
- Christopher Pieczonka Syracuse, NY Named on 24 payments
- Ryan Malone Jeffersonville, IN Named on 24 payments
- Matthew Truesdale Largo, FL Named on 18 payments
- Edward King Ocala, FL Named on 11 payments
- Jeffrey Pearl Mount Prospect, IL Named on 11 payments
- Raymond Lance Spokane, WA Named on 7 payments
- Ronald Tutrone Baltimore, MD Named on 7 payments
- Bryan Mehlhaff Springfield, OR Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.